The role of somatostatin analogs in the management of hepatocellular carcinoma.
D'Agostino
L
L
Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy. luciano@unina.it
Manguso
F
F
Pivonello
R
R
Colao
A
A
D018931:Antineoplastic Agents, Hormonal / Q000378:metabolism / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D022781:Hepatocytes / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D013004:Somatostatin